ArticleDiscover oncology2025

Transient Receptor Potential Melastatin 4 (TRPM4) is associated with an immuno-stimulatory TME and better prognosis in BLCA.

Yiqiang Da et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.